According to the latest report
published by Credence Research, Inc. “Next Generation Sequencing Market –
(Technology Type – Whole Genome Sequencing, Targeted Resequencing, RNA
Sequencing, Whole Exome Sequencing, and De Novo Sequencing); (Application –
Oncology, Genetic Screening, Infectious Diseases, Drug and Biomarker Discovery,
Agriculture & Animal Research, Idiopathic Diseases and others): Market
Growth, Future Prospects and Competitive Analysis,
2016-2024” the market was valued at USD 2.6 Bn in 2015, and is
expected to reach USD 20.6 Bn by 2025, expanding at a CAGR of 21.5% from 2016
to 2025.
Browse the full report Next
Generation Sequencing Market: Market Growth, Future Prospects and Competitive
Analysis, 2016-2025 report at http://www.credenceresearch.com/report/next-generation-sequencing-market
Market Insights
Next generation sequencing is a
high-throughput sequencing that enables sequencing and assembling of number of
short DNA reads at a small period of time and with a better accuracy. The
introduction of next generation sequencing technologies has ensured massive
changes in the sequencing process by providing better output, higher speed,
flexibility and reduced sequencing cost over thousand folds. Technologically,
the approaches for any next generation sequencing procedure can be categorized
into whole genome sequencing, targeted resequencing, Rna sequencing, whole
exome sequencing and de novo sequencing. With the advancement in technology and
development of high throughput sequencing platforms such as HiSeq and MiSeq, it
has become increasingly efficient to sequence larger number of base pairs in
single cycle reads. Targeted resquencing held the largest share in the global
next generation sequencing market due to its accuracy, and its rising
preferences in the research and development. De novo sequencing is anticipated
to grow at the fastest rate during the forecast period due to its faster, more
accurate characterization of any species compared to traditional methods.
Next-generation sequencing (NGS)
technologies have progressive advantages in terms of cost-effectiveness, unprecedented
sequencing speed, high resolution and accuracy in genomic analyses.
Technological developments in the next generation sequencing market are
expected to enable researchers to generate phase resolved HLA sequences in
single read cycles and provide insight into the lesser accessible regions of
HLA genes. Furthermore, the development of prenatal genome sequencing for
analysis of genetic anomalies and diseases is also expected to witness enhanced
demand, thus driving the genetic screening market. Growing incidences of cancer
and infectious diseases, and increasing use of next generation sequencing to
develop biopharmaceuticals and drugs for their cure are further expected to
drive demand for next generation sequencing.
Geographically, North America was observed
as the largest revenue generating market for next generation sequencing market,
where the U.S. held the largest market share. The major factors driving the
market are technological advancements in the field of life sciences,
availability of commercial solutions for next generation sequencing data
analysis, and presence of key players in the region. Moreover, extended support
from the government institution for genomic research for drug discovery and
genetic screening is also driving the market for next generation sequencing in
North America and Europe. Asia-Pacific is expected to grow at the fastest rate
with throughout the forecast period owing to growing medical awareness in the
regional population, increasing investment for development of healthcare and
rising oncology and infectious disease research in the region.
Market Competition Assessment:
The next generation sequencing
market currently possesses numerous companies having their products marketed,
however, Illumina, Inc. dominates the market wholly. Most of the companies are
located in the North America and others developed regions. The companies have
untapped opportunities in the developing regions of Asia Pacific and Latin
America. Companies are coming up with various products in the developed nations
due to high acceptance and accessibilities of these products. The companies
include, ThermoFisher Scientific, Pacific Biosciences of California,
F.Hoffman-La Roche AG Qiagen, BGI and Others.
Key Market Movements:
- Continuous introduction of new products and high level of accuracy offered by the products have accelerated the demand of next generation sequencers
- Extended clinical application of the next generation sequencing technologies in the field of various diseases and drug discovery driving the market
ToC:
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Next Generation Sequencing Market Portraiture
2.2 Next Generation Sequencing Market, by Technology, 2016 (US$ Mn)
2.3 Next Generation Sequencing Market, by Application, 2016 (US$ Mn)
2.4 Next Generation Sequencing Market, by Geography, 2016 (Value %)
2.1 Next Generation Sequencing Market Portraiture
2.2 Next Generation Sequencing Market, by Technology, 2016 (US$ Mn)
2.3 Next Generation Sequencing Market, by Application, 2016 (US$ Mn)
2.4 Next Generation Sequencing Market, by Geography, 2016 (Value %)
Chapter 3 Global Next Generation
Sequencing Market Analysis
3.1 Global Next Generation Sequencing Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Driver 1
3.2.1.2 Driver 2
3.2.1.3 Driver 3
3.2.2 Challenges
3.2.2.1 Challenge 1
3.2.2.2 Challenge 2
3.2.3 Opportunities
3.2.3.1 Opportunity 1
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Next Generation Sequencing Market, 2016 (Value
%)
3.1 Global Next Generation Sequencing Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Driver 1
3.2.1.2 Driver 2
3.2.1.3 Driver 3
3.2.2 Challenges
3.2.2.1 Challenge 1
3.2.2.2 Challenge 2
3.2.3 Opportunities
3.2.3.1 Opportunity 1
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Next Generation Sequencing Market, 2016 (Value
%)
Chapter 4 Global Next Generation
Sequencing Market, By Technology
4.1 Overview
4.2 Whole Genome Sequencing
4.3 Targeted Resequencing
4.4 RNA Sequencing
4.5 Chip Sequencing…
4.1 Overview
4.2 Whole Genome Sequencing
4.3 Targeted Resequencing
4.4 RNA Sequencing
4.5 Chip Sequencing…
Browse the full report Next
Generation Sequencing Market: Market Growth, Future Prospects and Competitive
Analysis, 2016-2025 report at http://www.credenceresearch.com/report/next-generation-sequencing-market
About Us:
Credence Research is a worldwide
Market research and counseling firm that serves driving organizations,
governments, non-legislative associations, and not-for-benefits. We offer our
customers some assistance with making enduring enhancements to their execution
and understand their most imperative objectives. Over almost a century, we’ve
manufactured a firm extraordinarily prepared to this task.
Our Blogs:
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
No comments:
Post a Comment